Clinical trial
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00440063 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00440063 |
|---|---|
| Title | A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. |
| Official title | A Randomized Study to Compare the Safety and Effectiveness of Two Monitoring Schedules to Maintain Hemoglobin Levels and Iron Parameters in Patients With Renal Anemia Receiving NeoRecormon |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | epoetin beta [NeoRecormon] |
| First posted | Feb 26, 2007 |
| Last update posted | Dec 20, 2007 |
| Countries | Australia |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: